Global Clinical Chemistry Analyzer Market Forecast Report by Product Type (Analyzers, Reagents, Others) Test Type (Basic Metabolic Panel, Liver Panel, Renal Profile, Lipid Profile, Thyroid Function Panel, Electrolyte Panel, Specialty Chemical tests) End User (Hospitals, Diagnostic Laboratory, Research Laboratories & Institutes, Others) Countries and Company Analysis, 2024-2032

Growing rates of chronic and lifestyle diseases, as well as an aging population:

The older population is growing significantly in both industrialized and developing countries, which is contributing to an increase in the prevalence of age-related illnesses such diabetes, hypertension, cardiovascular diseases, liver, and renal problems. As a result, there is an increased demand for management and diagnostic instruments, such as lipid profiles, liver and kidney panels, and basic metabolic panels. These tests are becoming more and more in demand since they are crucial for the diagnosis, treatment, and prevention of chronic illnesses. The need for clinical chemistry analyzers is further fueled by the increased emphasis on preventative medicine. The market is anticipated to gain from these aspects, propelling its expansion in the forecast future, as these tests are carried out utilizing clinical chemistry analyzers.

The field of clinical chemistry analyzers is always changing:

The clinical chemistry analyzers market is anticipated to gain from technological improvements throughout the projected period, offering several profitable expansion chances. Transasia's display of enhanced in-vitro diagnostic (IVD) products at the Medical Fair 2022, which includes the clinical chemistry analyzer Erba XL 640 with an autoloader, is one instance of this. This state-of-the-art equipment improves overall client experience by increasing productivity, decreasing manual work for staff members, and enabling faster turnaround times (TAT).

Government policies, programs, and funding intended to encourage the expansion of labs and diagnostics are also expected to provide a boost to the market. These advantageous policies offer promising futures for companies in the clinical chemistry analyzers market. With these things taken into account, there should be plenty of room for growth in the market during the projected time, which will result in a larger market.

North America Clinical Chemistry Analyzer Market

During the study period, the market growth is anticipated to be primarily influenced by the North American region. The increasing incidence of chronic illnesses, growing healthcare costs, and product developments by the top regional market players are the main drivers of market expansion in the area.

The most common cause of mortality and disability in the US each year is chronic illness, according to CDC statistics on the condition that was most recently updated in July 2022. The country's growing chronic illness rate contributes to the North American clinical chemistry analyzer market's expansion. Other significant aspects propelling the expansion of the studied market in the North American region include the high prevalence of chronic diseases and the target in the area, as well as the growing desire for early diagnoses. For example, the Canadian Cancer Society's 2021 study estimates that there will be over 229,200 new instances of cancer diagnosed in Canada in 2021; also, 628 Canadians receive a cancer diagnosis on average each day, and this number is anticipated to rise in the future. In addition, the same report states that, excluding non-melanoma skin cancer, the most common cancers diagnosed in Canada are lung, breast, colorectal, and prostate cancers.

New technologically improved items are being introduced into the market by the key players in the industry. For example, Thermo Fisher Scientific and Mindray joined in February 2021 to offer two clinical chemistry analyzers to customers in the US and Canada for use in forensic and clinical laboratories for drug screening. Toxicology labs can purchase the USD FDA-cleared and Health Canada-approved BS-480 (400 tests/hour) and BA-800M (800 tests/hour) analyzers from Thermo Fisher and Mindray.

Global Clinical Chemistry Analyzer Company Analysis:

Some leading Clinical Chemistry Analyzer companies are Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Johnson & Johnson, Sysmex ADR, HORIBA, Ltd., Hitachi.

Global Clinical Chemistry Analyzer Company News:

July 2023: The FDA has approved Beckman Coulter Diagnostics' DxC 500 AU Chemistry Analyzer, an automated device intended for small-to-medium-sized labs. The analyzer supports efficiency and reliability in diagnostic testing by offering standardized tests that improve clinical decision-making and patient outcomes with proven Six Sigma performance.

May 2023: The Atellica HEMA 570 and 580 Analyzers from Siemens Healthineers are designed for high-volume hematology testing. These technologies' user-friendly interfaces, multi-analyzer automation connectivity, and rules-based testing simplify workflows and give doctors and patients rapid, accurate findings.

March 2023: The Binding Site Group was acquired by Thermo Fisher Scientific for a total of £2.3 billion (USD 2.8 billion). Thermo Fisher's Specialty Diagnostics division is now larger with the inclusion of The Binding Site, especially in cancer testing for multiple myeloma.

Product – Market Breakup in 3 Viewpoints

1. Analyzers
2. Reagents
3. Others

Test Type – Market Breakup in 7 Viewpoints

1. Basic Metabolic Panel
2. Liver Panel
3. Renal Profile
4. Lipid Profile
5. Thyroid Function Panel
6. Electrolyte Panel
7. Specialty Chemical tests

End Users – Market Breakup in 4 Viewpoints

1. Hospitals
2. Diagnostic Laboratory
3. Research Laboratories & Institutes
4. Others

Geography – Market Breakup of 23 countries

North America

•    United States
•    Canada
•    Colombia

Europe

•    France
•    Germany
•    Italy
•    Spain
•    United Kingdom
•    Netherlands

Asia Pacific

•    China
•    Japan
•    India
•    Australia
•    South Korea
•    Malaysia
•    Indonesia
•    Israel

Latin America

•    Brazil
•    Mexico
•    Argentina

Middle East & Africa

•    South Africa
•    Saudi Arabia
•    UAE

Rest of the World

Company Insights:

•    Overview
•    Recent Development
•    Product Portfolio
•    Revenue

Key Players Analysis:

1. Thermo Fisher Scientific
2. Abbott Laboratories
3. Siemens Healthineers
4. Danaher Corporation
5. Johnson & Johnson
6. Sysmex ADR
7. HORIBA, Ltd.
8. Hitachi Hologic, Inc.

Report Details: